Delinquent payments hurting marijuana operators nationwide, survey shows

Delinquent payments are causing a cascade of problems for small and large cannabis operators nationwide, according to a new report by Oregon-based cannabis data and research company Whitney Economics.

Retiring Blumenauer reflects on his marijuana advocacy, makes bold prediction

U.S. Rep. Earl Blumenauer, who will not seek reelection next year, talks about his role as a marijuana advocate.

FDA considered state data in marijuana rescheduling, documents show

The Food and Drug Administration considered data regarding marijuana’s medical value submitted by U.S. states with legal cannabis programs when determining how the drug should be federally classified, newly released documents suggest.

Bipartisan marijuana descheduling bill reintroduced in Congress

Bipartisan legislation that would remove state-legal marijuana from the federal Controlled Substances Act and leave individual markets in charge of most other regulation was reintroduced in Congress on Thursday.

Democratic governors ask Biden to reschedule marijuana before end of year

Six Democratic governors have formally asked the Biden administration to move on rescheduling marijuana before the end of the calendar year.

Rescheduling marijuana would liberate plant-touching firms from Section 280E

If and when rescheduling becomes law, regulated marijuana business owners in the United States would enjoy an enormous tax cut, as the notorious IRS Section 280E would no longer apply.

Rescheduling could foster marijuana acceptance from health care industry

Moving marijuana from Schedule 1 to Schedule 3 under the Controlled Substances Act could influence whether and how doctors recommend medical cannabis.

Legal and retail gurus explain how Schedule 3 could impact marijuana sales

If marijuana is moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, that would expand both access and product selection for medical marijuana patients. But rescheduling likely wouldn’t impact how state-regulated MMJ dispensaries operate.

Will rescheduling reroute the future of interstate commerce for cannabis?

Some cannabis executives are hopeful that if the federal government moves marijuana from Schedule 1 to 3 of the Controlled Substances Act, then transporting MJ products across state lines will be allowed.

DEA likely to OK marijuana rescheduling, but election and lawsuits could get in the way

From zealous drug warrior to out-of-touch elder statesman to the regulated marijuana industry’s savior apparent.

President Joe Biden’s long arc in public life might have more twists ahead.

Republican-led federal marijuana legalization effort reappears in Congress

A bipartisan but Republican-led effort to legalize marijuana federally was reintroduced in Congress last week, but chances for passage might be slim in the House under new Speaker Mike Johnson.

Marijuana companies suing US attorney general in federal prohibition challenge

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.